A service of StreetInsider.com
Ticker Symbol
Welcome

Most Popular

AAPL 493.17
C 33.66
GOOG 611.46
BAC 8.18
RIMM 15.90

Recently Added

CPIC 1.19
SHMX 0.00
NBTH 12.50
COHO 0.00
PZZI 4.71

Gaining Speed

COHO 0.00
SHMX 0.00
CPIC 1.19
NBTH 12.50
AVEW 0.00
45.06 +0.00 (0.00%) GSK

Click Here to Receive Instant E-mail and RSS Alerts


Trade GSK now with

Stock Details

Last Trade:45.06 Change:+0.00 (0.00%) Prev Close:45.06 Open: 393.38 Days Range:45.06 – 45.06 52 Week Range: 36.39 - 46.50 Volume:127060 P/E: N/A
EPS:0.00





Recent Blog Posts

Blog Posts on 02/09/12 at 3:14pm
Sanofi's Balanced Model Looks Undervalued
Blog Posts on 02/09/12 at 1:00pm
5 Dividend King Income Stocks For Retirees
Blog Posts on 02/09/12 at 10:39am
5 Defensive Stocks For A Highly Volatile Market
Blog Posts on 02/08/12 at 6:48pm
GlaxoSmithKline: A Good Mix Of Income And Opportunity
Blog Posts on 02/08/12 at 6:22pm
U.K. Mega Caps Earnings And Dividend Update
Blog Posts on 02/07/12 at 7:23pm
Big Pharma's Potential Consumer Growth Avenue
Blog Posts on 02/07/12 at 3:30pm
GlaxoSmithKline plc's CEO Discusses Q4 2011 Results - Earnings Call Transcript
Blog Posts on 02/07/12 at 3:10pm
Big, Robust Pipelines At Small Biotech Companies
Blog Posts on 02/07/12 at 10:46am
IPO Preview: ChemoCentryx
Blog Posts on 02/07/12 at 10:06am
Trading Biotech In Pairs: A Better Way To Hedge
Blog Posts on 02/07/12 at 5:30am
5 Defensive Stocks For A Very Volatile Market
Blog Posts on 02/06/12 at 3:27pm
Protecting Your Merck Investment
Blog Posts on 02/06/12 at 11:16am
Biopharma Report Card: 2-Week Checkup
Blog Posts on 02/06/12 at 6:31am
Small Pharma With Big Compounds: Final Dance With The FDA
Blog Posts on 02/03/12 at 8:36am
Response Genetics Stock Soars 31% On $7.8M Offering News
Blog Posts on 02/03/12 at 5:14am
The Birth Control Pill Fiasco: Will It Be Bad For Pfizer?
Blog Posts on 02/02/12 at 6:55am
Verastem: Killing Cancer At The Root
Blog Posts on 01/31/12 at 4:53pm
Sizing Up The Healthcare Sector's January Dogs
Blog Posts on 01/31/12 at 2:15pm
GlaxoSmithKline Poised To Break 52-Week High
Blog Posts on 01/30/12 at 9:07am
Verastem IPO Validates Investor Interest In Cancer Stem Cell Approach
Blog Posts on 01/29/12 at 4:34am
Arena Pharmaceuticals Has Over A 300% Upside Potential In 2012
Blog Posts on 01/27/12 at 12:14pm
Vertex Pharmaceuticals Could See Huge Long-Term Gains
Blog Posts on 01/27/12 at 11:40am
Trius Therapeutics: Weakness Presents Opportunity
Blog Posts on 01/27/12 at 10:07am
Executing And Creating Value, Neurocrine Biosciences Is Worth Watching
Blog Posts on 01/26/12 at 6:13am
Teva Partnership And Pipeline Potential: Why Antares Is A Buy
Blog Posts on 01/25/12 at 11:20am
IPO Preview: Verastem
Blog Posts on 01/25/12 at 2:41am
Top Hepatitis C Virus Biotech Picks By The World's Largest Fund Managers
Blog Posts on 01/24/12 at 5:11pm
5 Super Stocks For A Safe Retirement Portfolio
Blog Posts on 01/24/12 at 9:37am
5 Excellent Dividend Stocks For Retirement Income
Blog Posts on 01/23/12 at 3:47pm
Can These 4 Stocks Compete Against Their Peers Over The Long Run?